134 related articles for article (PubMed ID: 30549028)
1. Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone.
Baumhoer D; Kovac M; Sperveslage J; Ameline B; Strobl AC; Krause A; Trautmann M; Wardelmann E; Nathrath M; Höller S; Hardes J; Gosheger G; Krieg AH; Vieth V; Tirabosco R; Amary F; Flanagan AM; Hartmann W
J Pathol; 2019 May; 248(1):116-122. PubMed ID: 30549028
[TBL] [Abstract][Full Text] [Related]
2. Non-ossifying fibroma: A RAS-MAPK driven benign bone neoplasm.
Bovée JV; Hogendoorn PC
J Pathol; 2019 Jun; 248(2):127-130. PubMed ID: 30809793
[TBL] [Abstract][Full Text] [Related]
3. Non-ossifying fibroma with a pathologic fracture in a 12-year-old girl with tricho-rhino-phalangeal syndrome: a case report.
Su W; Shi X; Lin M; Huang C; Wang L; Song H; Zhuang Y; Zhang H; Li N; Li X
BMC Med Genet; 2018 Dec; 19(1):211. PubMed ID: 30541476
[TBL] [Abstract][Full Text] [Related]
4. Making sense of giant cell lesions of the jaws (GCLJ): lessons learned from next-generation sequencing.
Gomes CC; Diniz MG; Bastos VC; Bernardes VF; Gomez RS
J Pathol; 2020 Feb; 250(2):126-133. PubMed ID: 31705763
[TBL] [Abstract][Full Text] [Related]
5. Clonal complex chromosome aberration in non-ossifying fibroma.
Brassesco MS; Valera ET; Engel EE; Nogueira-Barbosa MH; Becker AP; Scrideli CA; Tone LG
Pediatr Blood Cancer; 2010 May; 54(5):764-7. PubMed ID: 20077467
[TBL] [Abstract][Full Text] [Related]
6. Oestrogen receptor expression distinguishes non-ossifying fibroma from other giant cell containing bone tumours.
Cleven AHG; Schreuder WH; Groen E; de Lange J; Briaire-de Bruijn IH; Bovée JVMG
Virchows Arch; 2022 Oct; 481(4):671-675. PubMed ID: 35612673
[TBL] [Abstract][Full Text] [Related]
7. TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw.
Gomes CC; Gayden T; Bajic A; Harraz OF; Pratt J; Nikbakht H; Bareke E; Diniz MG; Castro WH; St-Onge P; Sinnett D; Han H; Rivera B; Mikael LG; De Jay N; Kleinman CL; Valera ET; Bassenden AV; Berghuis AM; Majewski J; Nelson MT; Gomez RS; Jabado N
Nat Commun; 2018 Nov; 9(1):4572. PubMed ID: 30385747
[TBL] [Abstract][Full Text] [Related]
8. Scintigraphic characteristics of non-ossifying fibroma in military recruits undergoing bone scintigraphy for suspected stress fractures and lower limb pains.
Hod N; Levi Y; Fire G; Cohen I; Ayash D; Somekh M; Horne T
Nucl Med Commun; 2007 Jan; 28(1):25-33. PubMed ID: 17159546
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets.
Lyu J; Song Z; Chen J; Shepard MJ; Song H; Ren G; Li Z; Guo W; Zhuang Z; Shi Y
J Pathol; 2018 Mar; 244(3):358-366. PubMed ID: 29230811
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Molecular Characteristics of NF1-Mutant Lung Cancer.
Redig AJ; Capelletti M; Dahlberg SE; Sholl LM; Mach S; Fontes C; Shi Y; Chalasani P; Jänne PA
Clin Cancer Res; 2016 Jul; 22(13):3148-56. PubMed ID: 26861459
[TBL] [Abstract][Full Text] [Related]
11. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
[TBL] [Abstract][Full Text] [Related]
12. KRAS Mutations in Papillary Fibroelastomas: A Study of 50 Cases With Etiologic and Diagnostic Implications.
Bois MC; Milosevic D; Kipp BR; Maleszewski JJ
Am J Surg Pathol; 2020 May; 44(5):626-632. PubMed ID: 32141886
[TBL] [Abstract][Full Text] [Related]
13. Brown Tumors Belong to the Spectrum of KRAS -driven Neoplasms.
Turek D; Haefliger S; Ameline B; Alborelli I; Calgua B; Hartmann W; Harder D; Flanagan AM; Amary F; Baumhoer D
Am J Surg Pathol; 2022 Nov; 46(11):1577-1582. PubMed ID: 36040039
[TBL] [Abstract][Full Text] [Related]
14. Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.
Vannelli S; Buganza R; Runfola F; Mussinatto I; Andreacchio A; de Sanctis L
Ital J Pediatr; 2020 May; 46(1):58. PubMed ID: 32393377
[TBL] [Abstract][Full Text] [Related]
15. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
[TBL] [Abstract][Full Text] [Related]
16. Two cases of multiple ossifying fibromas in the jaws.
Wang TT; Zhang R; Wang L; Chen Y; Dong Q; Li TJ
Diagn Pathol; 2014 Mar; 9():75. PubMed ID: 24678936
[TBL] [Abstract][Full Text] [Related]
17. Non-ossifying fibroma: natural history with an emphasis on a stage-related growth, fracture risk and the need for follow-up.
Herget GW; Mauer D; Krauß T; El Tayeh A; Uhl M; Südkamp NP; Hauschild O
BMC Musculoskelet Disord; 2016 Apr; 17():147. PubMed ID: 27044378
[TBL] [Abstract][Full Text] [Related]
18. Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma.
Udager AM; McHugh JB; Betz BL; Montone KT; Livolsi VA; Seethala RR; Yakirevich E; Iwenofu OH; Perez-Ordonez B; DuRoss KE; Weigelin HC; Lim MS; Elenitoba-Johnson KS; Brown NA
J Pathol; 2016 Aug; 239(4):394-8. PubMed ID: 27234382
[TBL] [Abstract][Full Text] [Related]
19. Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.
Hirata Y; Brems H; Suzuki M; Kanamori M; Okada M; Morita R; Llano-Rivas I; Ose T; Messiaen L; Legius E; Yoshimura A
J Biol Chem; 2016 Feb; 291(7):3124-34. PubMed ID: 26635368
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor (EGFR), KRAS, and BRAF mutations in lung adenocarcinomas: A study from India.
Singh V; Guleria P; Malik PS; Mohan A; Thulkar S; Pandey RM; Luthra K; Arava S; Ray R; Jain D
Curr Probl Cancer; 2019 Oct; 43(5):391-401. PubMed ID: 30591192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
